Gastonia Pharmacy to Pay $204,000 to Resolve Alleged Controlled Substances Act Violations
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Gastonia Pharmacy to Pay $204,000 to Resolve Alleged Controlled Substances Act Violations

Gastonia Pharmacy to Pay $204,000 to Resolve Alleged Controlled Substances Act Violations

February 27, 2025
|
Share Article
|
Download Press Release
For Immediate Release
Contact: SA Crystal Harper
Phone Number: (571) 362-3433

CHARLOTTE, N.C. – Prescriptions Plus, a pharmacy in Gastonia, N.C., has agreed to pay $204,000 to resolve allegations that it violated the recordkeeping requirements of the Controlled Substances Act, announced Acting U.S. Attorney Lawrence J. Cameron. 

The Controlled Substances Act was enacted to combat illegal distribution and abuse of controlled substances, including prescription medications. Pharmacies dispensing controlled substances must register with the Drug Enforcement Administration (DEA) and comply with the various requirements of the Controlled Substances Act, including to maintain complete and accurate records of all controlled substances received, sold, or otherwise disposed of. These recordkeeping requirements play a vital role in ensuring the appropriate handling, accounting, and distribution of controlled substances. Violations of the recordkeeping requirements subject pharmacies to civil monetary penalties. 

The United States alleges that Prescriptions Plus did not adequately monitor the conduct of its staff pharmacist and failed to keep complete and accurate records regarding the receipt and distribution of controlled substances, including oxycodone and alprazolam. The United States contends that these violations negligently enabled the illegal distribution of oxycodone and alprazolam by its staff pharmacist. 

Prescriptions Plus represents that it has taken steps to improve its compliance with the Controlled Substances Act, including by implementing new recordkeeping policies. As part of the resolution, Prescriptions Plus has entered into a Memorandum of Agreement with the DEA, addressing measures to ensure the pharmacy’s future compliance with the Controlled Substances Act. 

“DEA investigators will continue to aggressively pursue the unlawful dispensing practices of pharmacists, as was the case with the pharmacist working at Prescriptions Plus. The DEA is committed to making sure healthcare providers are abiding by the law,” said Jae W. Chung, Acting Special Agent in Charge of the Atlanta Field Division of the DEA, which oversees the Charlotte District Office. 

“When pharmacies fail to comply with the Controlled Substances Act, they can put opioids and other prescription drugs at risk of abuse on the street, causing great harm to our communities,” said Acting U.S. Attorney Cameron. “Our Office is committed to working with the Drug Enforcement Administration to hold pharmacies accountable when they fail to take required steps to prevent unlawful drug distribution.” 

This investigation was conducted by the DEA Charlotte District Office Tactical Diversion Squad with assistance from the Gastonia Police Department, DEA Greensboro Resident Office Diversion Group, DEA Columbia District Office Diversion Group, North Carolina Board of Pharmacy, and IRS Charlotte Criminal Investigation Division. 

Assistant U.S. Attorney Holly H. Snow handled this affirmative civil enforcement matter on behalf of the Government. 

The claims resolved by the settlement are allegations only and there has been no determination of liability. 

Download Press Release
###
Oxycodone
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Robert Murphy Special Agent in Charge - Atlanta
@DEAAtlantaDiv
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster